As described in another study, patients with discordant lesions represent a cohort of patients with very poor prognosis as these lesions tend to harbor de-differentiated PC cells, without PSMA expression, which are in most cases not suitable for radionuclide treatment and have grown resistant to most conventional PC therapies [27]. This evidence concerns the gene FOLH1 and pachyonychia congenita.